Front PageNational News Pakistan
Send News Request
National•International Bureau•16 Nov 2026, 09:55 PM PKT•2 min read•1,807 Reads

Lgalmi: US FDA approves at-home use of agitation drug

Lgalmi: US FDA approves at-home use of agitation drug. National News Pakistan correspondents report that administrative desks and on-ground observers are closely monitoring developments across Pakistan.

60-Second Editorial Quick Summaryخلاصہ

Verified facts & intelligence briefed by National News Press Bureau.

Lgalmi: US FDA approves at-home use of agitation drug — reported as a key national national development in Pakistan.



Official statements and regulatory updates are actively monitored by the NNP Central Wire.

NNP Central Editorial Research Desk
#Pakistan National Bureau#National Desk
WhatsApp𝕏 PostFacebook
Lgalmi: US FDA approves at-home use of agitation drug
Photo: National News Pakistan Bureau

INTERNATIONAL BUREAU —

Key Takeaways & Executive Analysis

  • Promotional image shared by Bioxcel The US Food and Drug Administration on Monday approved at-home use of BioXcel Therapeutics’ drug, Igalmi, ​for agitation associated with schizophrenia or bipolar ‌disorder.
  • According to field observations and verified reporting compiled by the International bureau desk: The company last month completed the sale of nearly all its assets, including Igalmi, to a unit of ​Teva Pharmaceuticals.
  • The approval expands Igalmi’s use to outpatient settings without supervision of a healthcare provider, where there are no FDA-approved options available, Teva said.
Verified National Coverage: Published by National News Press (International Bureau). Fact-checked and verified.
Verified Editorial Desk
WhatsApp𝕏 PostFacebook

Audience Reviews & Discussion

Share your perspective, rate coverage accuracy, and engage with verified readers across Pakistan.

Rate This Story

Join the Discussion

Civic discussion moderated by NNP Editorial Desk

Community Comments (0)